| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
NZK - FY25 (Sept) - GHG Statement
|
27 Nov 2025 7:35AM |
$0.195 |
$0.180 |
fallen by
7.69%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
NZK - FY25 (Sept) Investor Presentation
|
27 Nov 2025 7:34AM |
$0.195 |
$0.180 |
fallen by
7.69%
|
|
NZK - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for FY25 (Sept) was NZ$117.7 million, down 44% year-on-year.
- The presentation covers an eight-month period due to a change in the financial year-end.
- Volume sold decreased significantly due to reduced harvest volumes.
- Biomass rebuilding efforts are underway, following subdued feed outs earlier in the period.
- Gross profit and EBITDA both saw declines, attributed to reduced earnings and increased mortality.
- Price increases and a product mix shift partially offset volume declines.
- Focus remains on core investments, including the Blue Endeavour ocean farming project.
- Operational leverage continues to be a challenge due to high fixed and semi-variable costs.
- NZK anticipates increased corporate costs to support growth initiatives.
- The company is undertaking significant capital investments to ensure future growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
NZK - FY25 (Sept) Annual Report
|
27 Nov 2025 7:34AM |
$0.195 |
$0.180 |
fallen by
7.69%
|
|
| Pacific Edge Limited (PEB) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$159 |
Pacific Edge Appoints Chief Commercial Officer
|
27 Nov 2025 7:33AM |
$0.140 |
$0.155 |
risen by
10.71%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
FY25 (Sept) NZK Results Announcement
|
27 Nov 2025 7:32AM |
$0.195 |
$0.180 |
fallen by
7.69%
|
|
NZK - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 44% to NZD 117,719,000.
- Net loss of NZD 6,327,000 reported.
- No dividends declared for the period.
- Net tangible assets per share remained at NZD 0.37.
- Report covers an 8-month period ending in September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$97 |
FY25 (Sept) Media Announcement
|
27 Nov 2025 7:32AM |
$0.195 |
$0.180 |
fallen by
7.69%
|
|
NZK - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss for the period was $6.3 million.
- Pro-forma EBITDA decreased to $7.1 million.
- Sales volumes and revenue saw significant declines.
- Strategic investments are planned for core strengthening and growth.
- FY26 guidance includes a pro-forma EBIT range of a $3 million loss to a $3 million profit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryman Healthcare Limited (RYM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$2,610 |
1H26 results - NZX announcement numbers
|
27 Nov 2025 7:31AM |
$2.510 |
$2.570 |
risen by
2.39%
|
|
RYM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryman Healthcare Limited reported results for the 1H26 period ending 30 September 2025.
- Total revenue was NZD 413,780, representing a 12.97% increase from the previous period.
- The company reported a net loss of NZD 45,194 from continuing operations, a decline of 155.11%.
- There is no dividend declared for the 6 months ended 30 September 2025.
- Net tangible assets per quoted equity security decreased slightly from NZD 4.106 to NZD 4.060.
- Prior comparative periods have been restated, as noted in the Consolidated Interim Financial Statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryman Healthcare Limited (RYM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$2,610 |
1H26 results - presentation
|
27 Nov 2025 7:31AM |
$2.510 |
$2.570 |
risen by
2.39%
|
|
RYM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryman Healthcare's village operations generated an increase in care and village fees to $317 million in 1H26.
- Deferred management fees collected grew slightly to $42.9 million.
- Village capital expenditure decreased to $13.3 million.
- Overall village cash flow reduced to $43.3 million.
- Resales of occupation rights saw a notable decrease in gross receipts to $74.4 million.
- Ryman Healthcare's total aged care revenue rose to $207.6 million, with room premiums growing by 17%.
- The company maintained high occupancy rates, although mature care center occupancy slightly declined to 96.1%.
- Non-village operating costs decreased significantly by 27%, showcasing effective cost control measures.
- Operating EBITDAF significantly increased to $40.1 million, driven by improved performance in both mature and developing villages.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ryman Healthcare Limited (RYM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$2,610 |
1H26 results - media release
|
27 Nov 2025 7:31AM |
$2.510 |
$2.570 |
risen by
2.39%
|
|
RYM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryman Healthcare reported its first positive free cash flow in over a decade.
- Total revenue increased by 13%, driven by growth in pricing and utilization.
- Net loss after tax was $45.2 million, affected by reduced fair value movements.
- Ryman completed a full bank refinancing of $2.0 billion.
- Sales guidance for FY26 was raised to 1,300–1,400 ORA sales.
- Ryman's aged care occupancy remains high with robust demand.
- Ryman listed on the ASX on 1 October 2025, expanding access for investors.
- A comprehensive review of Ryman's capital management framework is underway.
- Government reforms in New Zealand and Australia are impacting funding models for aged care.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$338 |
Synlait updates forecast base milk price
|
27 Nov 2025 7:30AM |
$0.580 |
$0.560 |
fallen by
3.45%
|
|
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$615 |
Tower reports record FY25 result, increased dividends
|
27 Nov 2025 7:30AM |
$1.680 |
$1.795 |
risen by
6.85%
|
|
TWR - Price-sensitive ASX Announcement
Full Release
Key Points
- Tower Limited reported a record underlying NPAT of $107.2 million for FY25, up from $83.5 million in FY24.
- Reported profit was $83.7 million, an increase from $74.3 million in FY24.
- Gross written premium grew by 2% to $600 million.
- Customer numbers increased by 4% to 318,000.
- The BAU claims ratio improved to 41% from 48% in FY24.
- A fully imputed final dividend of 16.5 cents per share was declared, bringing total dividends for FY25 to 24.5 cents per share.
- Tower's Board aimed to distribute benefits from lower large events costs to shareholders.
- Tower launched a new partnership with Westpac NZ to offer general insurance products to their retail customers.
- The company achieved a reduction in the natural hazards portion of premiums for 90% of existing customers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chorus Limited (CNU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$3,519 |
Chorus EMTN tender offer - results
|
27 Nov 2025 7:30AM |
$8.130 |
$8.110 |
fallen by
0.25%
|
|
| Spheria Emerging Companies Limited (SEC) ORDINARY FULLY PAID |
Financials |
$171 |
Net Tangible Asset Backing
|
26 Nov 2025 8:28PM |
$2.730 |
$2.850 |
risen by
4.40%
|
|
| Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$185 |
Results of Annual General Meeting
|
26 Nov 2025 8:26PM |
$0.265 |
$0.310 |
risen by
16.98%
|
|
| Bega Cheese Limited (BGA) ORDINARY FULLY PAID |
Consumer Staple |
$1,826 |
Ceasing to be a substantial holder
|
26 Nov 2025 8:25PM |
$6.030 |
$5.980 |
fallen by
0.83%
|
|
| ARB Corporation Limited (ARB) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,621 |
Becoming a substantial holder
|
26 Nov 2025 8:25PM |
$33.870 |
$31.400 |
fallen by
7.29%
|
|
| Amplitude Energy Limited (AEL) ORDINARY FULLY PAID |
Energy |
$861 |
Becoming a substantial holder
|
26 Nov 2025 8:24PM |
$2.860 |
$2.870 |
risen by
0.35%
|
|
| Zeus Resources Limited (ZEU) ORDINARY FULLY PAID |
Energy |
$8 |
Results of Meeting
|
26 Nov 2025 8:24PM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$5,793 |
Change in substantial holding from MUFG
|
26 Nov 2025 8:21PM |
$5.200 |
$5.210 |
risen by
0.19%
|
|
| Rent.com.au Limited (RNT) ORDINARY FULLY PAID |
Communication Services |
$54 |
Becoming a substantial holder
|
26 Nov 2025 8:20PM |
$0.050 |
$0.049 |
fallen by
2%
|
|
| Rent.com.au Limited (RNT) ORDINARY FULLY PAID |
Communication Services |
$54 |
Ceasing to be a substantial holder
|
26 Nov 2025 8:19PM |
$0.050 |
$0.049 |
fallen by
2%
|
|
| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$118 |
Change of Director's Interest Notice
|
26 Nov 2025 8:16PM |
$0.038 |
$0.038 |
fallen by
0%
|
|
| Jupiter Mines Limited. (JMS) ORDINARY FULLY PAID |
Materials |
$541 |
Annual General Meeting Results
|
26 Nov 2025 8:16PM |
$0.265 |
$0.275 |
risen by
3.77%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$50 |
Final Director's Interest Notice - AM
|
26 Nov 2025 8:15PM |
$0.011 |
$0.016 |
risen by
45.45%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$50 |
Final Director's Interest Notice - JS
|
26 Nov 2025 8:15PM |
$0.011 |
$0.016 |
risen by
45.45%
|
|